| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |